↓ Skip to main content

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease

Overview of attention for article published in Drugs, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy
1 policy source
patent
3 patents

Citations

dimensions_citation
174 Dimensions

Readers on

mendeley
122 Mendeley
Title
Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease
Published in
Drugs, September 2012
DOI 10.2165/00003495-200969050-00004
Pubmed ID
Authors

Stephen I. Rennard, Donald P. Tashkin, Jennifer McElhattan, Mitchell Goldman, Sulabha Ramachandran, Ubaldo J. Martin, Philip E. Silkoff

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Australia 1 <1%
Unknown 119 98%

Demographic breakdown

Readers by professional status Count As %
Other 22 18%
Researcher 19 16%
Student > Master 14 11%
Student > Bachelor 9 7%
Student > Ph. D. Student 8 7%
Other 29 24%
Unknown 21 17%
Readers by discipline Count As %
Medicine and Dentistry 57 47%
Pharmacology, Toxicology and Pharmaceutical Science 12 10%
Nursing and Health Professions 7 6%
Agricultural and Biological Sciences 6 5%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 12 10%
Unknown 24 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2019.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from Drugs
#833
of 3,464 outputs
Outputs of similar age
#39,054
of 189,082 outputs
Outputs of similar age from Drugs
#278
of 1,461 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,464 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 1,461 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.